Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline.

Tanneau, Lénaïg; Karlsson, Mats O; Diacon, Andreas H; Shenje, Justin; De Los Rios, Jorge; Wiesner, Lubbe; Upton, Caryn M; Dooley, Kelly E; Maartens, Gary; Svensson, Elin M

Tanneau, Lénaïg; Karlsson, Mats O; Diacon, Andreas H; Shenje, Justin; De Los Rios, Jorge; Wiesner, Lubbe; Upton, Caryn M; Dooley, Kelly E; Maartens, Gary; Svensson, Elin M.

Affiliation

Tanneau L; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Karlsson MO; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Diacon AH; TASK Applied Science, Cape Town, South Africa.
Shenje J; SATVI, University of Cape Town, Cape Town, South Africa.
De Los Rios J; Barranco Clinical Research Site, Asociacion Civil Impacta Salud y Educacion, Lima, Peru.
Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Upton CM; TASK Applied Science, Cape Town, South Africa.
Dooley KE; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Svensson EM; Department of Pharmacy, Uppsala University, Uppsala, Sweden. elin.svensson@farmaci.uu.se.

Clin Pharmacokinet ; 61(8): 1177-1185, 2022 08.

Article in En | MEDLINE | ID: mdl-35668346

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Tuberculosis, Multidrug-Resistant / Nitroimidazoles Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Clin Pharmacokinet Year: 2022 Document type: Article Affiliation country: Suecia Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google